In this case, at least partial delivery of TTC-HEXA to the secondary lysosomes is suggested by its capability to reduce the accumulated lysosomal substrates in the cortical cell cultures of feline TSD model [48]; whereas neuroprotective effects of Bcl-xL-TTC [72] may indicate mitochondrial targeting. Here, BCL2L1 is linked to Tay-Sachs disease.